During the course of studies designed to assess the effect of human Ha-ras gene expression on the malignant behavior of transfected mouse tumor cells we noted that the process of Ca3(PO4)2-mediated DNA transfection was itself associated with profound alterations in tumorigenic or metastatic behavior. The cell line used as a recipient for these studies was a tumorigenic nonmetastatic CBA/J mouse mammary adenocarcinoma line called SP1. When cotransfected with plasmids containing the neo gene (pSV2neo) and the activated Ha-ras gene (pT24-c3), cells from the pooled (5-10 colonies) G418-resistant colonies gave rise to spontaneous lung metastases in 85% of mice after subcutaneous inoculation. However, we noted that 17% of control mice inoculated with G418-resistant pSV2neo-transfected SP1 cells also had lung metastases and that this number approached 100% as the inoculum comprised a greater pool size (50-100 colonies). When cell lines established from isolated pSV2neo-transfected colonies were examined, 3/16 were found to be metastatic. We also found that 3/16 clones grew slowly, or not at all, in CBA/J mice, whereas they grew readily in athymic (nude) mice. The increase in immunogenicity of two out of three of these latter clones was accompanied by expression of the class I H-2Dk major histocompatibility complex antigen that was not detectable in the parental SP1 cells. At least some of these results would appear to be due to exposure to Ca3(PO4)2 alone, as we found that it resulted in 5/20 (25%) clones manifesting metastatic properties. Our results suggest that heritable changes in malignant behavior of transfected tumor cells can be observed at high frequency subsequent to the process of Ca3(PO4)2-mediated DNA transfection, and these changes may be brought about in part by inherited disturbances in expression of recipient cell genes.
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The advent of gene transfection techniques has had an enormous impact on developing an understanding of gene structure and function. This is particularly true in the field of carcinogenesis, where the functions of oncogenes or putative oncogenes have been dissected in depth by the use of such procedures (1, 2) . More recently, gene transfection techniques have also been employed to study aspects of tumor progression and metastasis at the genomic or gene level (3) . A potential problem with gene transfection studies stems from the possibility that elements of the transfection and subsequent selection procedures themselves may cause acquired phenotypic alterations. The magnitude of this problem may not be so serious-or apparent-in tumorigenic transformation studies using immortalized cell lines, where one is concerned with the emergence of tumors and in which, presumably, the transfer of an oncogene is necessary for development of the neoplastic phenotype. But in situations in which alterations in existing malignant behavior are under scrutiny, the inherent genetic instability of tumor cells (4) may make them particularly vulnerable to genetic alterations induced by DNA transfection techniques and subsequent selection procedures.
With regard to the latter possibility there are two especially noteworthy points. First, it has already been shown that transfection of plasmids containing oncogene sequences into nontumorigenic fibroblastic cells can result in secondary chromosomal changes that lead to neoplastic transformation without stable integration of the transfected oncogene (i.e., "hit-and-run" tumorigenesis) (5) . There are also examples of "insertional mutagenesis," usually involving stable insertion of viral or proviral sequences into the genome of the recipient or infected cells (e.g., see refs. 6-8). Second, although one might assume that such events would be very rare at any given locus, it is now apparent that conventional mutagenic agents can sometimes cause very high frequency heritable phenotypic alterations due to inherited disturbances in gene expression at single gene loci (9, 10) . Among the possible mechanisms that could bring this about is induced changes in DNA methylation (11) (12) (13) . Thus, if the procedure of DNAmediated transfection is directly mutagenic, then, like other mutagens, it may also cause, or be associated with, inherited changes in gene expression at frequencies far higher than those normally associated with classical mutations.
In this paper we present evidence that Ca3(P04)2-mediated transfection of a nonimmunogenic and very poorly metastatic aneuploid mouse mammary adenocarcinoma (the nature of which is described in ref. 14) is associated with the emergence of a high frequency of either less aggressive or more aggressive variants, and the changes are heritable. As such, the results have important implications for the study of neoplasia and control of gene expression in general, and tumor progression/metastasis studies in particular, using gene transfection techniques.
MATERIALS AND METHODS
Tumors. CBA.SP1 (abbreviated SP1) is a nonmetastatic infiltrating mammary intraductal adenocarcinoma that arose spontaneously in an 18-month-old female retired breeder of the inbred CBA/J mouse strain. The characteristics of this aneuploid tumor (which has a mode of 68-72 chromosomes) have been described in detail elsewhere (14) . Subcutaneous inoculation of 105 uncloned SP1 cells in the lower right-hand flank leads to progressively growing encapsulated tumors.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Cells were either transfected with pSV2neo (17) or cotransfected with pSV2neo plus pT24-c3 (18) , which carries the human T24 bladder carcinoma Ha-ras oncogene, at a molar ratio of 1:10. No carrier DNA was used in these transfections, which incorporated a glycerol shock (19) . Cells were subcultured into G418 (GIBCO; 400 ,g/ml) selective media 48 hr after DNA transfection, and drug-resistant (G418f) colonies were harvested 14-17 days later.
DNA Extraction and Filter Hybridization. High molecular weight genomic DNA was extracted from cultured cells as described (20) . Solid primary tumor tissue was pulverized in liquid nitrogen by using a mortar and pestle prior to DNA extraction. DNA digested with restriction endonuclease was separated by electrophoresis, transferred to nitrocellulose according to the method of Southern (21), prehybridized, and hybridized as previously described (20) (14) . Immunofluorescence detection procedures were carried out as previously described (14) .
RESULTS
Transfected Cells Are Capable of Metastatic Growth. Table  1 reports the results of two experiments in which SP1 cells were either transfected with the pSV2neo plasmid alone or cotransfected with pSV2neo plus pT24-c3, a plasmid carrying the human T24 bladder carcinoma Ha-ras oncogene (18) . Our approach was similar to that described by others in relationship to transfection of Ha-ras into 3T3 cells, primary embryo fibroblasts, or mouse mammary tumor cells (3, 26, 27) . In the first experiment 5-10 transfected G418' colonies were isolated, pooled, and grown to mass culture. Approximately 105 of these cells were injected subcutaneously into syngeneic mice to assess their capacity for metastatic growth. As shown in Table 1 , the pSV2neo + Ha-ras cotransfected cells gave rise to lung metastases in 85% of the animals tested. A high incidence of metastasis was also observed after inoculation of single Ha-ras-transfected SP1 clones, all of which expressed transfected ras sequences at various levels (unpublished results). A significant number of animals (17%) inoculated with cells transfected with pSV2neo alone also gave rise to metastases, whereas none were detected after subcutaneous injection of the uncloned parental SP1 cell line. In the second experiment (Exp. 2 in Table 1 ), in which the inoculum comprised a larger pool of individually derived pSV2neo transfectants (50-100 colonies), virtually every animal developed metastases. If it is assumed that only a fraction of SP1 cells acquire metastatic potential after transfection with pSV2neo, then it follows that the likelihood of detecting malignant cells would increase when the inoculum comprised a larger number of individual transfectants. Since a G418r cell line (SP1 neoKi; Table 1 ) derived from a metastatic tumor was found to be highly metastatic after inoculation into syngeneic mice, we conclude that at least some of the malignant cells generated after transfection and drug selection have stably acquired a metastatic phenotype. In all these experiments the number of tumor nodules in the lungs was modest-between 1 and 10-and the nodules were approximately 1-2 mm in diameter at 6-8 weeks after tumor cell inoculation (Table 1) . This is not unusual for spontaneous metastasis of epithelial tissue tumors (carcinomas).
pSV2neo Metastases Result from a Limited Number of Transfected Cells. Southern analysis of mass cultures of pooled pSV2neo-transfected colonies and cultUres derived from individual metastases supports the premise that only a small number of pSV2neo-transfected clones are capable of metastatic growth. As shown in Fig. 1 , all of the metastatic tumors derived from pSV2neo-transfected cells retained plasmid sequences. Digestion of genomic DNA with BamHI, a single cutter of pSV2neo, generates two unique fragments for each insertion and a 5.8-kilobase (kb) fragment, reflecting Table 2 and summarized in Table 3 , confirm and extend our results obtained with the pooled cultures. Thus, 3 of the 16 pSV2neo-transfected clones were able to metastasize to the lungs, whereas none of the 20 SP1 clones showed any sign of metastatic growth. tThis line is still unconfirmed as an authentic tum-clone.
In addition to the high frequency of metastasis-positive transfected clones observed, our analysis unexpectedly revealed that 3 of the 16 pSV2neo G418r clones were considerably less (or non-) tumorigenic in syngeneic CBA/J micei.e., they behaved as tum-clones (14) . We also noted that 3 of the 20 SP1 clones obtained by simple in vitro cloning also grew poorly when first tested in groups of three CBA/J mice. These clones were not "authentic" tum-clones, however, because the phenotype was not reproducible when cells from the same frozen batch of cells were thawed, grown to mass culture, and then retested. This type of variation has been seen for a variety of parameters and is probably due to random and unstable clonal variation (30) . In contrast, the 3 tum-pSV2neo clones maintained their tum-phenotype when similarly retested. However, these tum-pSV2neo clones grow normally in 100% of nude mice, suggesting an immunological basis for reduction of their tumorigenicity in CBA/J mice. The observed effects on the metastatic and tumorigenic phenotype of SP1 cells are not specific to transfection with pSV2neo, as similar results were obtained after transfection and selection with pSV2gpt (Table 3) . Indeed, treatment of SP1 cells with Ca3(PO4)2 for 16 hr prior to cloning yielded 5 metastatic clones out of a total of 20 (i.e., 25%). However, no authentic tum-clones have yet been observed after Ca3-(PO4)2 treatment alone. Although the number of individual clones tested was limited, we have also found that both nontumorigenic and metastatic clones were obtained after transfection of independent SP1 clones with pSV2neo (Table  3) . This argues against the possibility that the process of DNA transfection and selection inadvertently selects for rare metastatic or nontumorigenic variants within the uncloned parental SP1 population.
tum-Clones Are Often Associated with Increased Expression of MHC Class I Antigens. The development of tum-cells after DNA transfection is reminiscent of our previous findings with agents such as ethyl methanesulfonate and 5-azacytidine (14, 31, 32) . The tum-phenotype in these latter studies was often found to be associated with an increase in class I MHC (H-2) surface antigens (14) . On analysis of the tum-clones generated after DNA transfection and selection of pSV2neo colonies, we found that once again the tum+ tum-phenotypic change was associated with an altered expression of MHC class I antigens. Samples of SP1 and SP1 neo+ clones were screened by fluorescence-activated cell sorter (FACS) analysis for MHC expression in a double blind experiment. All but two clones were found to be H-2 negative, like the SP1 parental cell line. The two H-2-positive clones were identified as two of the three tum-pSV2neo clones-i.e., SP1 neo4 and SP1 neo24. Fig. 2 shows a representative sample of the FACS analysis of SP1 cells and three clones, two of them being authentic tum-clones (SP1 neo4 or neo24). As in previous studies (14) using alkylating agents or 5-azacytidine, it was the H-2Dk antigen, not the H-2Kk antigen, that was expressed. did not grow in three CBA/J mice but did so upon retesting of frozen and thawed cells; SP1 neo4 and SP1 neo24 are cell lines established from independent G418T colonies (clones) obtained after transfection with pSV2neo. All other SP1 clones were found to be H-2Kk-and H-2Dk-negative, as were G418r SP1 transfectants that manifested a tumorigenic (tum+) phenotype in CBA/J mice. The H-2Dk-positive phenotype was found in 2/3 pSV2neo SP1 transfectants-i.e., the ones shown above. heritable alterations in both the tumorigenic and malignant behavior of the transfectants at a high frequency. Using the highly tumorigenic but nonmetastatic mouse mammary adenocarcinoma, SP1, we have observed that transfection of SP1 cells with pSV2neo alone gave rise to lung metastases in a significant number of animals. Analysis of independent pSV2neo-transfected G4181 clonal isolates revealed that almost 20% of these clones manifested metastatic potential. We also noted that 3/16 of pSV2neo transfectant clones showed an increased immunogenic phenotype in that they had a greatly impaired ability to grow in syngeneic CBA mice while being able to grow in 100% of athymic (nu/nu) mice.
The latter observation was strikingly reminiscent of observations indicating that treatment of tumor cell lines with highly mutagenic alkylating agents, such as ethyl methanesulfonate or poorly mutagenic agents that can alter gene expression, such as 5-azacytidine, can result in very high frequencies (between 10% and 90%) of tum-clones (31, 33) . Indeed, this has been observed with the SP1 mammary carcinoma itself (14, 32) , in which it was also found that tum-SP1 clones manifested an increase in the expression of self class I MHC antigens, specifically of H-2Dk (14) . As With respect to which components of the transfection procedure are important in effecting these phenotype changes, our results indicate that treatment of SP1 cells with Ca3(PO4)2 alone can lead to alterations in the metastatic potential of these cells, indicating this procedure can account for at least some of our results. The absence of detectable tum-clones after Ca3(PO4)2 treatment alone may mean that it is irrelevant to the induction of this phenotype or that Ca3(PO4)2 treatment in combination with some other component of the DNA transfection process (e.g., G418 selection) may be necessary to generate tum-clones at high frequency. It should be noted that Rubin and co-workers have described results showing both growth-stimulating (proliferative) effects and morphological changes on BALB/c 3T3 cells by precipitates of calcium ortho-or pyrophosphate (34) (35) (36) .
Our results have broad implications for the interpretation of experimental results involving gene transfection procedures, since it is obvious that in some cases the observed phenotype of transfectants may not necessarily be a manifestation of the product of the transferred gene. In respect to neoplasia it is noteworthy in our experiments that we chose to (i) examine metastasis rather than just tumorigenicity; (ii) use normal immunocompetent mice as well as, or instead of, nude mice; and (iii) test clones as well as pooled colonies of G418r cells. As a result, we detected gross changes in the malignant, tumorigenic, and immunogenic status in many of the transfectants, some of which would have gone undetected had we confined our analysis to the relative tumorigenicity of pooled colonies in nude mice.
